Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults

Translated title of the contribution: Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults

P.A.J.T. Robe, D.H. Martin, M.T. Nguyen-Khac, M. Artesi, M. Deprez, A. Albert, S. Vanbelle, S. Califice, M. Bredel, V. Bours

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionEarly termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults
Original languageUndefined/Unknown
Pages (from-to)372-372
Number of pages1
JournalBMC Cancer
Volume9
Publication statusPublished - 2009

Cite this